Compare the Efficacy of Aspartate Aminotransferase to Platelet Index (APRI) and FIB-4 with Transient Elastography: FibroScan in Patients with Chronic Hepatitis C

Objective: Compare the efficacy of aspartate aminotransferase in patients with chronic hepatitis fibro scan to platelet index and FIB-4 transient elastography. Study Design: Cross-sectional study. Place & Duration Study: Department Medicine, Azhra Naheed Medical College, Lahore from 1st May 2020 31st October 2020. Methodology: Eleven hundred fifty both sexes were enrolled. Demographic after written consent have been registered. Both had a detailed history, clinical review investigations designed rule out misunderstanding partiality findings research. The diagnosis was perfectly performed for continuing C infection, which included various biochemical tests. We contrasted efficiency readily available aminotrasnferase scansand distinguishing progression virus fibrosis. Results: Mean age 39.14±14.68 years mean BMI 22.68±9.14kg/m2. Seven thirty (63.5%) females 420 (36.5%) males. Almost 70% HCV on stage F0-F1 6.5% F2 15.7%, 16.97% F3 F4. No significant difference observed regarding mortality rate p value <0.05. Conclusion: Aspartate aminotransferase/platelet FIB4 are expected reliably separate cirrhotic non-cirrhotic stages expensive unusual rating infected patients. Keywords: Hepatitis C, Fibrosis, Liver, aminostransferase (AST)